Tarsus to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tarsus (NASDAQ:TARS) announced that management will participate in two upcoming investor conferences: the William Blair 46th Annual Growth Stock Conference/b] on June 2 at 8:00 a.m. PT / 11:00 a.m. ET and the on June 3 at 8:40 a.m. PT / 11:40 a.m. ET.

Live webcasts, details, and limited-time replays will be available in the events section of the Tarsus website.

News Market Reaction – TARS

-0.24%

-0.24% Session close to close

In the May 29 session, TARS declined 0.24%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:

• William Blair 46^th Annual Growth Stock Conference on Tuesday, June 2^nd, at 8:00 a.m. PT / 11:00 a.m. ET.
• 2026 Jefferies Global Healthcare Conference on Wednesday, June 3^rd, at 8:40 a.m. PT / 11:40 a.m. ET.
  
  

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 as an ophthalmic gel for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, both of which are in Phase 2.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When will Tarsus (NASDAQ:TARS) present at the William Blair 46th Annual Growth Stock Conference?

Tarsus is scheduled to present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2 at 8:00 a.m. PT / 11:00 a.m. ET. According to Tarsus, investors can access the live webcast through the events section of its website.

What time is Tarsus (TARS) presenting at the 2026 Jefferies Global Healthcare Conference?

Tarsus plans to present at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3 at 8:40 a.m. PT / 11:40 a.m. ET. According to Tarsus, the presentation will be available via live webcast on the company’s events webpage.

How can investors access the Tarsus (TARS) webcasts for the June investor conferences?

Investors can access live webcasts of both June investor conference presentations through the events section of the Tarsus website. According to Tarsus, additional information about each appearance will also be posted there for shareholders and analysts following the company.

Will replays of the Tarsus (TARS) June investor conference presentations be available online?

Yes, replays of the Tarsus June investor conference webcasts will be available on the company’s website within 48 hours. According to Tarsus, these replays will remain archived for a limited time in the events section for later viewing.

Where on the Tarsus website can investors find details about upcoming investor conferences?

Investors can find conference details on the Tarsus website in the dedicated events section. According to Tarsus, this area hosts access links for live webcasts, schedule information, and replay archives related to the company’s investor conference participation.